FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1503501000168106: sarilumab 200 mg / 1.14 mL injection, 1.14 mL syringe (medicinal product unit of use)

Status: current, Defined. Date: 30-Nov 2020. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4478951000168115 sarilumab 200 mg / 1.14 mL injection, 1.14 mL syringe (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4478961000168118 sarilumab 200 mg/1.14 mL injection, syringe en Synonym Active Case sensitive Australian Medicines Terminology module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
sarilumab 200 mg/1.14 mL injection, syringe Is a sarilumab true Inferred relationship Some
sarilumab 200 mg/1.14 mL injection, syringe Is a medicinal product unit of use true Inferred relationship Some
sarilumab 200 mg/1.14 mL injection, syringe has manufactured dose form injection true Inferred relationship Some
sarilumab 200 mg/1.14 mL injection, syringe has unit of use syringe true Inferred relationship Some 1903086471
sarilumab 200 mg/1.14 mL injection, syringe has Australian BoSS sarilumab true Inferred relationship Some 2093898079
sarilumab 200 mg/1.14 mL injection, syringe has intended active ingredient sarilumab true Inferred relationship Some 2093898079
Inbound Relationships Type Active Source Characteristic Refinability Group
Kevzara 200 mg/1.14 mL injection, 1.14 mL syringe Is a True sarilumab 200 mg/1.14 mL injection, syringe Inferred relationship Some
sarilumab 200 mg/1.14 mL injection, 2 x 1.14 mL syringes has MPUU True sarilumab 200 mg/1.14 mL injection, syringe Inferred relationship Some 2105291894

Reference Sets

Medicinal product unit of use reference set

Back to Start